GlassScriptPhysician profile
Parth J Patel
NPI 1689168791
$515.89
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.74 · 2021: $44.35 · 2022: $152 · 2023: $233 · 2024: $73.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $161.37 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Glaxosmithkline, LLC. | $84.40 | 2022-2023 | Shingrix |
| Teva Pharmaceuticals USA, INC. | $47.19 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.37 | 2022-2023 | Spiriva Respimat, Stiolto Respimat |
| Astellas Pharma US INC | $36.26 | 2024 | Veozah |
| Novo Nordisk INC | $28.81 | 2021-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $25.08 | 2022-2024 | Airsupra |
| Heartflow, INC. | $24.28 | 2024 | |
| Abbvie INC. | $18.93 | 2022 | |
| Avanir Pharmaceuticals, INC. | $16.97 | 2022 | |
| Medtronic, INC. | $16.49 | 2023 | Clydesdale Ptc Spinal System |
| Eisai INC. | $12.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parth Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.